Marché mondial des sacs intraveineux vides (IV) – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse du marché et de la taille des sacs intraveineux (IV) vides

En médecine vétérinaire, les sacs intraveineux (IV) vides servent d'outils essentiels pour administrer des liquides, des médicaments et d'autres traitements aux animaux. Les vétérinaires comptent sur les sacs IV pour assurer l'hydratation, administrer des médicaments et soutenir les interventions de soins intensifs pendant les interventions chirurgicales, les urgences et les traitements médicaux pour les animaux. Ces sacs sont disponibles dans différentes tailles et configurations pour s'adapter aux différentes espèces animales et aux exigences de traitement. Qu'il s'agisse de petits animaux de compagnie tels que les chats et les chiens ou de gros animaux d'élevage tels que les chevaux et les bovins, les sacs IV jouent un rôle essentiel dans les soins de santé vétérinaires en garantissant un dosage précis et une administration sûre des thérapies intraveineuses.

La taille du marché mondial des sacs intraveineux (IV) vides était évaluée à 3,91 milliards USD en 2023 et devrait atteindre 5,96 milliards USD d'ici 2031, avec un TCAC de 5,40 % au cours de la période de prévision de 2024 à 2031.

Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée du rapport et segmentation du marché       

Définition du marché

Empty intravenous (IV) bags refer to medical containers designed to hold various intravenous fluids, such as saline solution or medications, but are devoid of content. They are typically made of flexible plastic and come in various sizes to accommodate different volumes of fluids. These bags are crucial in healthcare settings for administering treatments directly into the bloodstream. Once filled with the required solution or medication, they are connected to IV lines and used for intravenous therapy, transfusions, or hydration. Empty IV bags are sterile and disposable, ensuring patient safety and hygiene during medical procedures.

Empty Intravenous (IV) Bags Market Dynamics

Drivers                                                                                          

• Rising Prevalence of Chronic Diseases

Chronic diseases such as cancer, diabetes, and cardiovascular disorders often require ongoing intravenous therapies for medication administration, hydration, and nutritional support. As the incidence of chronic diseases continues to increase due to factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits, the need for IV bags for disease management and treatment escalates. Healthcare facilities, including hospitals, clinics, and home healthcare settings, require a consistent supply of IV bags to meet the growing demand for intravenous treatments.

• Increasing Technological Innovations in IV Bags

Advancements such as the development of more durable and flexible materials, improved closure systems to maintain sterility, and enhanced compatibility with various medications contribute to the market growth. Features such as integrated ports for easy access and administration of medications, as well as compatibility with infusion pumps and other medical devices, enhance the usability and efficiency of IV bags, driving their adoption in healthcare settings.

Opportunities

• Expansion of Home Healthcare Services

As healthcare shifts towards decentralized models and patients seek alternatives to traditional hospital stays, there's a rising demand for IV bags to facilitate intravenous therapies in the comfort of patients' homes. Home healthcare services offer convenience and cost-effectiveness for managing chronic conditions, post-operative care, and palliative treatments, driving the need for IV bags for fluid administration, medication delivery, and nutritional support outside clinical settings. This trend empowers patients to take greater control of their healthcare and creates a growing market for IV bags tailored for home use, with features emphasizing ease of use, portability, and safety.

• Rising Government Initiatives

Governments often invest in healthcare infrastructure, including hospitals and clinics, which increases the demand for IV bags for fluid administration during treatments and surgeries. Favorable reimbursement policies for intravenous therapies incentivize healthcare providers to utilize IV bags, boosting market growth. Government initiatives also focus on regulating the quality and safety standards of medical devices, including IV bags, ensuring their compliance with stringent regulations, which further stimulates market demand. Awareness campaigns and educational programs sponsored by governments raise awareness among healthcare professionals and patients about the importance of intravenous therapy, fostering the adoption of IV bags in clinical settings.

Restraints/Challenges

• High Concerns Regarding Plastic Pollution

As the healthcare industry increasingly recognizes the environmental impact of single-use plastics, there is growing pressure to seek alternative, more sustainable packaging solutions. The substantial use of plastic IV bags contributes to plastic waste generation, raising environmental concerns and prompting healthcare facilities to explore eco-friendly alternatives. Moreover, public awareness campaigns and regulatory initiatives aimed at reducing plastic consumption may lead to shifts in consumer preferences towards greener packaging options, potentially impacting the demand for traditional plastic IV bags.

• High Volatility in Raw Material Prices

Fluctuations in the prices of key materials, such as plastic resins, which are integral to IV bag manufacturing, can directly impact production costs. Manufacturers may face challenges in maintaining stable pricing for IV bags, leading to uncertainty for both producers and consumers. Sudden spikes in raw material prices can squeeze profit margins and hinder investment in innovation or expansion initiatives within the industry.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In February 2023, Bowmed Ibisqus Company launched Levofloxacin fluid bags in a ready-to-use format, wrapped with foil to shield the fluid from light. This innovation not only addressed the need for convenient IV solutions but also potentially impacted the demand for empty IV bags in the market as hospitals and healthcare facilities transitioned to this new format
• In January 2022, the U.S. FDA approved B. Braun Medical Inc.'s new pharmaceutical production facility in Daytona Beach, Florida. This facility was designated to manufacture 500 mL and 1,000 mL Excel Plus IV Bags with 0.9% Sodium Chloride for Injection, potentially contributing to the supply of empty IV bags in the market.
• In April 2021, Winpak Ltd. and Wipak Walothen GmbH collaborates to establish Wiicare, a brand focused on delivering healthcare packaging solutions, including medical fluid containers. This collaboration aimed to address the growing demand for innovative packaging solutions in the medical industry, potentially impacting the empty intravenous (IV) bags market

Empty Intravenous (IV) Bags Market Scope

The market is segmented on the basis of type, and product type. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• PVC
• Non-PVC

Product Type

• Single Chamber
• Multi-chamber

Empty Intravenous (IV) Bags Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, and product type as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Brazil, and Argentina.

North America dominates the market, primarily driven by the widespread adoption of non-PVC bags in the region. This trend is fueled by the increasing acceptance of innovative healthcare technologies. As a result, the demand for empty IV bags is expected to continue rising in North America throughout the forecast period. The region's proactive embrace of advancements in healthcare, including safer and more eco-friendly packaging solutions, further propels the growth trajectory of the empty IV bags market in this region.

Asia-Pacific is expected to experience substantial growth in the market, driven by several factors. These include high disease prevalence, particularly among the aging population, coupled with better reimbursement policies and escalating investments to enhance healthcare infrastructure. Furthermore, the increasing consumption of unhealthy food habits contributes to the rising demand for medical interventions, including intravenous therapies. However, despite these growth drivers, challenges such as low awareness about healthcare practices persist, influencing the market dynamics in the region.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et du marché des sacs intraveineux (IV) vides

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs opérant sur le marché sont :

• Sac Sippex IV (États-Unis)
• Technoflex (Japon)
• Groupe Wipak (Allemagne)
• Baxter (États-Unis)
• B. Braun (Allemagne)
• ICU Medical, Inc. (États-Unis)
• POLYCINE GmbH (Allemagne)
• RENOLIT SE (Allemagne)
• Pfizer Inc. (États-Unis)
• West Pharmaceutical Services Inc. (États-Unis)
• Jinan Youlyy Industrial Co., Ltd. (Chine)
• Jiangsu Eyoung Medical Devices Co. Ltd. (Chine)

SKU-68243